Tokyo, June 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061927) titled 'Exploratory Study on NAD+ Measurement Techniques Following NMN (Two Types) Intake' on June 17.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Dose comparison
Primary Sponsor:
Institute - DHC Corporation
Condition:
Condition - none
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Whole blood NAD levels and eight types of NMN-related metabolites
Basic objectives2 - PK,PD
Intervention:
Interventions/Control_1 - Type 1 NMN 350mg
Interventions/Control_2 - Type 2 NMN 250mg
El...